NL-OMON39041已完成不适用
Releasing the brakes on CD8+ T cells in the melanoma sentinel lymph node by pre-operative local administration of low-dose anti-CTLA-4 (tremelimumab) - Anti-CTLA-4 in the melanoma sentinel node
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Stage II melanoma
- •WHO 0-1 performance
排除标准
- •no auto-immune disease
- •no immune deficiency
研究者
相似试验
已完成
1 期
Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II MelanomaCutaneous MelanomaNCT04274816A.J.M. van den Eertwegh13
进行中（未招募）
1 期
Transfer of CMV specific T-cells for immunotherapy of CMV infection in pediatric patients after hematopoietic stem cell transplantatiochronic CMV infection after allogeneic hematopoietic stem cell transplantation in children, refractory to conventional antiviral treatmentEUCTR2012-001335-31-CZniverzita Karlova v Praze, 2. lékarská fakulta14
进行中（未招募）
1 期
EFFECT OF CD8+ T CELL ACTIVATION ON LIVE ATTENUATED HEPATITIS A VACCINE IN OBESITY/OVERWEIGHT CHILDREN AND YOUNG ADULTSObesityTCTR20210825005Ratchaphisek Sompoch Grant200
已完成
不适用
Breaking the Barrier: CD8+ T cells in Atopic Dermatitis and Psoriasis Vulgariseczema1000170810014982atopic dermatitisNL-OMON32531niversitair Medisch Centrum Utrecht36
已完成
不适用
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell TransplantationHematologic MalignancyALLCMLHodgkin's LymphomaMultiple MyelomaNHLAMLNCT00333190Dana-Farber Cancer Institute30